TD Cowen Initiates Coverage On Sagimet Biosciences with Outperform Rating
Portfolio Pulse from richadhand@benzinga.com
TD Cowen analyst Ritu Baral has initiated coverage on Sagimet Biosciences (NASDAQ:SGMT) with an Outperform rating.
August 08, 2023 | 1:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sagimet Biosciences has been initiated with an Outperform rating by TD Cowen analyst Ritu Baral.
The Outperform rating from TD Cowen analyst Ritu Baral indicates a positive outlook for Sagimet Biosciences. This could potentially lead to an increase in investor interest and a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100